| ●Editorial | Kurihara M | 4-5 | Full text | |
| ●2nd World Centenarian Initiative International Symposium on Alzheimer's Diseases Prevention Strategy: In search of the road to new horizon | 7-123 | Abstract | ||
| Organized by：Translational Research Informatics Center, Foundation for Biomedical Research and Innovation | ||||
| Opening remarks | Fukushima M | 10-1 | ||
| Congratulations | Shiozaki Y Matsumoto J Sato A | 12 13 14 | ||
| New Orange Plan and dementia prevention in Japan | Miura K | 15-20 | ||
| Pathological aspects of amyloid burden in AD | Mori H | 21-8 | ||
| Clinicopathological correlation in Alzheimer's Disease | Kalaria RN | 29-36 | ||
| Japan community-based study for identifying risk factors of Alzheimer's disease | Asada T | 37-42 | ||
| Community-based prevention of dementia in Japan | Suzuki T | 43-8 | ||
| Prevalence and progression of mild cognitive impairment: The Shanghai Aging Study | Ding D | 49-57 | ||
| Mechanisms of Alzheimer's disease measuring amyloid and tau in the Alzheimer's Disease Neuroimaging Initiative (ADNI) | Weiner MW | 58-65 | ||
| Brain imaging in Alzheimer's disease | Fukuyama H | 66-71 | ||
| Novel imaging biomarker for early detection of AD | Sobue G | 72-7 | ||
| Imaging of Aβ-linked brain milieu disruption | Ouchi Y | 78-84 | ||
| Discussion | 85-6 | |||
| Strategies for prevention of AD: Clinical trials considerations | Doody RS | 87-94 | ||
| Practical points in conducting clinical trials on Alzheimer's disease | Lee JH | 95-9 | ||
| Strategy to tackle MCI: A drug repositioning approach | Ihara M | 100-7 | ||
| Current and potential status of clinical trials for MCI and dementia in Asia | Chen C | 108-15 | ||
| Discussion | 116-7 | |||
| General discussion | 118-22 | |||
| Closing remarks | Fukushima M | 123 | ||
| ●The 30th Japan Association for International Health Congress 2015 Trend in global health and infectious diseases －from the three major infectious diseases and Ebola to neglected tropical diseases－ | 125-49 | Abstract | ||
| Chairpersons：Kita K，Hirabayashi F | ||||
| Challenges in Responding to Epidemics: Ebola, Meningitis, HIV | Van Gulik C | 127-32 | ||
| Cutaneous leishmaniasis (CL): Global burden and treatment's challenges | Arana B | 133-40 | ||
| End epidemics of HIV, tuberculosis and malaria by 2030－ambitious or attainable? | Kunii O | 141-9 | ||
| ●Original | ||||
| Preliminary study of neuro-immune cross-talk by gut microbiota for perioperative management in infants with congenital heart disease | Imamura O，Uyeda T， Saito Y，et al． | 151-64 | Full text | |
| ●Translation | ||||
| Sharing clinical trial data: A proposal from the International Committee of Medical Journal Editors | Taichman DB，Backus J， Baethge C，et al． （trans. by Saio T，Kurihara C） | 165-8 | Full text | |
| ●Instructions for authors［Japanese］&［English］ | 169-77 | Full text | ||
| ●Editor's note | Sugiyama Y | 179 | Full text | |